Dimerix (DXB.AX) Stock Performance
- 24‑hour performance (ending 02:39 PM CET, Wednesday 21 Oct 2026): down 2.38 %.
- Current price: AUD 0.21.
- Shares outstanding: 615 million.
- Market capitalisation: AUD 126.1 million.
- 24‑hour trading volume: AUD 40 000.
- Month‑end performance: down 12.77 %.
- 200‑day simple moving average: AUD 0.31.
- 52‑week high: AUD 0.66 (23 Dec 2025).
- 52‑week low: AUD 0.16 (11 Jun 2026).
Recent 24‑Hour Performance of Related Stocks
| Stock | 24‑hour change | Current price | Market capitalisation | P/E (if available) |
|---|---|---|---|---|
| Austral Australia (AR1.AX) | 0 % | AUD 0.06 | AUD 147.2 million | 5.99 |
| Atomic Eagle (AEU.AX) | –4 % | AUD 0.37 | AUD 147.5 million | – |
| Paradigm Biopharmaceuticals (PAR.AX) | –2 % | AUD 0.25 | AUD 146.8 million | – |
| Torque Metals (TOR.AX) | –2.63 % | AUD 0.18 | AUD 143.7 million | – |
| Vita Life Sciences (VLS.AX) | +0.72 % | AUD 2.79 | AUD 149.8 million | 14.17 |
Company Profile
Dimerix Limited is a biotechnology firm headquartered in Fitzroy, Australia. The company focuses on the development and marketing of drug therapies for patients with chronic kidney disease and conducts related clinical trials. Its operations serve the Australian market. Additional information is available on the company’s website at www.dimerix.com or through trading on the ASX All Markets.
